Ipsen
-
Ticker
Exchange
-
Industry
Drug Manufacturers - Major More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Paris, France
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic
…More cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation.
Ipsen also has a well-established Consumer Healthcare business. With total sales close to €2.5 billion in 2020, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,700 employees worldwide.
REPORT RATINGS
3.5 / 5.0 (2)
Ipsen reports have an aggregate usefulness score of 3.5 based on 2 reviews.
Ipsen
Most Recent Responsibility Report
MOST RECENT
2023 Responsibility Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Ipsen Sustainability Report, Ipsen Corporate Social Responsibility Report, Ipsen CSR Report, Ipsen Corporate Responsibility, Ipsen CR Report, Ipsen Citizenship Report, Ipsen ESG Report, and Ipsen Environmental Report online.